1. Home
  2. MRUS vs ASGN Comparison

MRUS vs ASGN Comparison

Compare MRUS & ASGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • ASGN
  • Stock Information
  • Founded
  • MRUS 2003
  • ASGN 1985
  • Country
  • MRUS Netherlands
  • ASGN United States
  • Employees
  • MRUS N/A
  • ASGN N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • ASGN Professional Services
  • Sector
  • MRUS Health Care
  • ASGN Consumer Discretionary
  • Exchange
  • MRUS Nasdaq
  • ASGN Nasdaq
  • Market Cap
  • MRUS 2.7B
  • ASGN 2.6B
  • IPO Year
  • MRUS 2016
  • ASGN 1992
  • Fundamental
  • Price
  • MRUS $43.06
  • ASGN $58.23
  • Analyst Decision
  • MRUS Strong Buy
  • ASGN Buy
  • Analyst Count
  • MRUS 13
  • ASGN 5
  • Target Price
  • MRUS $86.85
  • ASGN $96.40
  • AVG Volume (30 Days)
  • MRUS 872.0K
  • ASGN 525.2K
  • Earning Date
  • MRUS 05-07-2025
  • ASGN 04-23-2025
  • Dividend Yield
  • MRUS N/A
  • ASGN N/A
  • EPS Growth
  • MRUS N/A
  • ASGN N/A
  • EPS
  • MRUS N/A
  • ASGN 3.83
  • Revenue
  • MRUS $36,133,000.00
  • ASGN $4,099,700,000.00
  • Revenue This Year
  • MRUS $26.81
  • ASGN $1.37
  • Revenue Next Year
  • MRUS $23.85
  • ASGN $6.06
  • P/E Ratio
  • MRUS N/A
  • ASGN $15.19
  • Revenue Growth
  • MRUS N/A
  • ASGN N/A
  • 52 Week Low
  • MRUS $33.19
  • ASGN $55.95
  • 52 Week High
  • MRUS $61.61
  • ASGN $105.67
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 51.15
  • ASGN 35.29
  • Support Level
  • MRUS $33.19
  • ASGN $55.95
  • Resistance Level
  • MRUS $43.46
  • ASGN $60.96
  • Average True Range (ATR)
  • MRUS 3.53
  • ASGN 2.71
  • MACD
  • MRUS 0.34
  • ASGN 0.16
  • Stochastic Oscillator
  • MRUS 80.53
  • ASGN 27.34

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About ASGN ASGN Incorporated

ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.

Share on Social Networks: